The nice people at the Stem Cell Evidence Alert sent their update today. Much of it went over my head, but there were one or two snippets in there…
ARTICLE OF THE MONTH Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. |
NEW CLINICAL COMMENTARY / REVIEW Total
Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A
Multinational, Randomized, Noninferiority Phase III Study |
SELECTED ARTICLES
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma.
Baertsch, M. A., et al. (2021) Blood Cancer Journal 11(1):1.
Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia.
Craddock, C., et al. (2021) Journal of Clinical Oncology [record in progress].
Carfilzomib,
lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction
therapy for transplant-eligible, newly diagnosed multiple myeloma
patients (Myeloma XI+): Interim analysis of an open-label randomised
controlled trial.
Jackson, G. H., et al. (2021) PLoS Medicine 18(1):e1003454.
Lenalidomide
maintenance after autologous haematopoietic stem-cell transplantation
in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL)
multicentre, randomised, phase 3 trial.
Ladetto, M., et al. (2021) The Lancet. Haematology 2021;8(1):e34-e44.
Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD.
Mehta, R.S., et al (2021) Bone marrow transplantation [record in progress]
Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome
Myllymäki, M., et al. (2020) Blood 136(26):3070-3081.
Clinical
characteristics and outcomes of COVID-19 in haematopoietic stem-cell
transplantation recipients: an observational cohort study.
Sharma, A., et al. (2021) The Lancet. Haematology [record in progress].
Autologous
stem cell transplantation versus bortezomib for the first line
treatment of systemic light chain amyloidosis in the UK.
Sharpley, F.A., et al (2021) European Journal of Haematology [record in progress]
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.
Watkins, B., et al (2021) Journal of Clinical Oncology [record in progress].
No comments:
Post a Comment